Unknown OBSERVATIONAL NCT05166759

Incidence and Clinical Characteristics of Pulmonary Hypertension Secondary to ARDS in the Highland

Incidence and Clinical Characteristics of Pulmonary Hypertension Secondary to ARDS

Sponsor: Qinghai University

Conditions ARDS

Updated 4 times since 2022 Last updated: Dec 21, 2021 Started: Nov 25, 2021 Primary completion: Mar 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates ARDS and is currently ongoing. Qinghai University leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2022 — Dec 2023 [monthly]

Recruiting

First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Qinghai University
Southeast University, China

Data source: Southeast University, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xining, China